May 21, 2024

Scientists aim to stop harmful gut bacteria triggering Alzheimer’s

University of South Australia nano bio-scientist Dr Ibrahim Javed says tiny metabolites released by bad bacteria in the gut can travel to the brain, causing inflammation and triggering Alzheimer’s disease, for which there is no cure. [Shutterstock].

The phrase ‘you are what you eat’ was coined almost a century before Alois Alzheimer made his breakthrough in identifying brain disease, but the evidence is now clear that diet as well as age influences the brain.

A growing body of research suggests a correlation between Alzheimer’s disease and an unhealthy gut, and Australian scientists are hoping to take this a step further by exploring how harmful gut bacteria accesses the brain and leads to dementia.

University of South Australia nano bio-scientist Dr Ibrahim Javed says tiny metabolites released by bad bacteria in the gut can travel to the brain, causing inflammation and triggering Alzheimer’s disease, for which there is no cure.

In younger people this is less likely because the blood-brain barrier is much stronger, but this weakens as people age, allowing harmful substances to damage neurons. When the microbiome in the gut ages, it also loses the ability to fight disease.

By identifying how metabolites released by bad bacteria damage neurons – and hopefully developing new drug therapies to block them – Dr Javed says it should be possible to slow down or halt the progression of Alzheimer’s.

A second aim of the three-year research project is to investigate how probiotics and nutritional supplements, both of which contain friendly bacteria, can stamp out bad bacteria and stop metabolites escaping from the gut.

This follows on from several international clinical research studies that have demonstrated that probiotics improves digestive and cognitive issues in people with acute and chronic COVID-19.

“Our research indicates that harmful gut bacteria can trigger early onset dementia as well as accelerate dementia in patients already battling the neurodegenerative disease,” Dr Javed says.

“A poor diet is one of several factors that harms gut bacteria, increasing your chances of developing dementia. Ageing, lack of exercise, exposure to pesticides and genetics also play a role, although the latter is responsible for a very small number of cases. In most cases, dementia is preventable.”

Most types of bacteria are harmless – many are even essential for our survival – but bad bacteria create biofilms which cause gastrointestinal infections, chronic diseases, bowel cancer and brain diseases.

Alzheimer’s disease affects up to 55 million people worldwide and with an ageing population, this number is expected to double every 20 years, according to Alzheimer’s Disease International.

Early onset dementia – under the age of 65 – is becoming more common in the global population, attributed to preventable factors such as a poor diet and a sedentary lifestyle, smoking, excessive alcohol consumption, social isolation, exposure to pesticides and air pollution.

Dr Javed’s team is also collaborating with UniSA neuroscientist Associate Professor Larisa Bobrovskaya on a potential link between stress and Alzheimer’s disease, and whether women are more at risk.

A video explaining the research can be viewed at: https://youtu.be/vcVvayyU2JE 

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

Australia is set to get a Wegovy pill. How does it compare with weight‑loss injections?

Australia has approved its first GLP-1 weight-loss tablet, giving people an alternative to weekly injections such as Wegovy and Ozempic. But does taking a daily pill make losing weight any easier, and how do the results, side effects and costs compare? Read More

Researchers identify a possible cause of chronic pain after shingles

For some people, shingles pain does not end when the rash disappears. New research has identified how tiny particles in the blood called exosomes may interfere with nerve repair and keep pain-sensing neurons hypersensitive, offering a potential new pathway for treating long-term pain. Read More

Microdosing cannabis shows promise in slowing Alzheimer’s disease decline

A new clinical study suggests microdosing cannabis may help stabilise cognitive decline in people with mild Alzheimer’s disease, without causing a psychoactive high. Early findings point to a potential new approach to dementia care. Read More
Advertisement
Exit mobile version